These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Van Ameringen M; Mancini C; Patterson B; Bennett M Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009 [TBL] [Abstract][Full Text] [Related]
54. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014 [TBL] [Abstract][Full Text] [Related]
55. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder. Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999 [TBL] [Abstract][Full Text] [Related]